浮针疗法对类风湿关节炎患者临床疗效及外周血Th17/Tregs平衡的影响

doi:10.3760/cma.j.cn441417-20240930-21020

摘要/Abstract

摘要： 目的　探讨浮针疗法在治疗类风湿关节炎（RA）患者中的效果，以及对外周血Th17/Tregs平衡的影响。方法　采用前瞻性研究。研究对象为2022年7月至2023年9月西安市第五医院接受治疗的104例RA患者，应用随机数字表法将其分为两组，每组52例。对照组：男13例、女39例，年龄40～70（58.64±3.90）岁；接受常规抗风湿药治疗。试验组：男14例，女38例，年龄40～70（58.76±3.49）岁，在对照组基础上予以浮针疗法治疗。两组均治疗1个月。对比治疗前后中医证候积分（关节胀痛、肢冷麻木、屈伸不利）、28处关节疾病活动度评分（DAS-28）变化，外周血Th17/Tregs及实验室指标［类风湿因子（RF）、血沉（ESR）、C反应蛋白（CRP）］水平改变。统计学方法采用t检验、χ²检验。结果　治疗后，试验组总有效率高于对照组［92.31%（48/52）比76.92%（40/52）］，差异有统计学意义（χ²=4.727，P=0.030）；试验组关节胀痛、肢冷麻木、屈伸不利中医证候积分，以及血清CRP、ESR水平均低于对照组，差异均有统计学意义（均P<0.05）。治疗后，试验组DAS-28评分低于对照组［（3.05±0.78）分比（4.10±0.96）分］，差异有统计学意义（t=6.121，P<0.05）；两组外周血Th17/Tregs比值差异无统计学意义（t=1.357，P>0.05）。结论　浮针疗法能够提高RA患者临床治疗效果，降低中医证候积分与DAS-28评分，下调血清ESR、CRP水平，但不能调节Th17/Tregs平衡，临床应用浮针治疗类风湿关节炎时需要配合系统抗风湿治疗。

关键词: 类风湿关节炎, 辅助性T淋巴细胞, 调节性T淋巴细胞, 浮针疗法

Abstract:

Objective　The efficacy of floating needle therapy in treating patients with rheumatoid arthritis (RA) and its impact on the balance of Th17/Tregs in peripheral blood. Methods　A prospective study was conducted. The research subjects were 104 RA patients who received treatment at Xi'an Fifth Hospital from July 2022 to September 2023. They were divided into two groups using the random number table method, with 52 patients in each group. Control group: 13 males and 39 females, aged 40 to 70 (58.64 ± 3.90) years; received conventional anti-rheumatic drug treatment. Experimental group: 14 males and 38 females, aged 40 to 70 (58.76 ± 3.49) years. They were treated with floating needle therapy on the basis of the control group. Both groups were treated for one month. Compare the changes in TCM syndrome scores (joint swelling and pain, limb coldness and numbness, limited joint movement), 28-joint disease activity score (DAS-28), as well as the levels of peripheral blood Th17/Tregs and laboratory indicators [rheumatoid factor (RF), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP)]. Statistical methods employed t-test and χ² test. Results　After treatment, the total effective rate of the experimental group was higher than that of the control group [92.31% (48/52) vs. 76.92% (40/52)], and the difference was statistically significant (χ²=4.727, P=0.030). The scores of TCM syndromes related to joint swelling and pain, limb coldness and numbness, and limited joint movement in the experimental group, as well as the levels of serum CRP and ESR, were all lower than those in the control group, and the differences were statistically significant (all P<0.05). After the treatment, the DAS-28 score of the experimental group was lower than that of the control group [(3.05±0.78) points vs. (4.10±0.96) points], and the difference was statistically significant (t=6.121, P<0.05). There was no statistically significant difference in the ratio of Th17/Tregs between the two groups of peripheral blood (t=1.357, P>0.05). Conclusion　Floating needle therapy can enhance the clinical treatment effect of RA patients, reduce the TCM syndrome score, lower the levels of serum ESR, CRP and DAS-28 score, but it cannot regulate the balance of Th17/Tregs. When applying floating needle therapy for rheumatoid arthritis in clinical practice, it is necessary to combine with systemic anti-rheumatic treatment.

Key words: Rheumatoid arthritis, Helper T-lymphocytes, Regulatory T-lympho-cytes, Floating acupuncture therapy, Th17/Tregs

赵敏张倩魏长征曹毓佳吕艳艳赵花妮. 浮针疗法对类风湿关节炎患者临床疗效及外周血Th17/Tregs平衡的影响[J]. 国际医药卫生导报, 2025, 31(21): 3623-3627.

Zhao Min, Zhang Qian, Wei Changzheng, Cao Yujia, Lyu Yanyan, Zhao Huani. Effects of floating needle therapy on rheumatoid arthritis and its impact on the balance of peripheral blood Th17/Tregs[J]. International Medicine and Health Guidance News, 2025, 31(21): 3623-3627.

参考文献

[1] Gravallese EM, Firestein GS. Rheumatoid arthritis - common origins, divergent mechanisms[J]. N Engl J Med, 2023,388(6):529-542.DOI: 10.1056/NEJMra2103726.
[2] 王晶,朱美玉,康丽,等. 纳米脂质体药物在类风湿性关节炎治疗中的研究进展[J]. 国际医药卫生导报,2022,28(23):3337-3341. DOI:10.3760/cma.j.issn.1007-1245.2022.23.020.
[3] Chen F, Wang Y, Wang L, et al. Combination of methotrexate and leflunomide is efficient and safe for 60 patients with rheumatoid arthritis[J]. Comput Math Methods Med, 2022,2022:6829358.DOI: 10.1155/2022/6829358.
[4] 田杰祥,王钢,王佳,等. 中医外治法治疗类风湿关节炎滑膜炎研究进展[J]. 陕西中医,2020,41(1):131-133. DOI:10.3969/j.issn.1000-7369.2020.01.037.
[5] 钟桥生. 浮针治疗膝关节周围炎的临床效果研究[J]. 基层医学论坛,2021,25(28):4127-4129. DOI:10.19435/j.1672-1721.2021.28.060.
[6] 中华医学会风湿病学分会. 类风湿关节炎诊断及治疗指南[J]. 中华风湿病学杂志,2010,14(4):265-270. DOI:10.3760/cma.j.issn.1007-7480.2010.04.014.
[7] 郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:54-66.
[8] Singh H, Tanwar VS, Kalra A, et al. Implication and utility of DAS-28 squeeze in rheumatoid arthritis: an Indian experience[J]. Reumatismo, 2022,74(2).DOI: 10.4081/reumatismo.2022.1501.
[9] Jang S, Kwon EJ, Lee JJ. Rheumatoid arthritis: pathogenic roles of diverse immune cells[J]. Int J Mol Sci, 2022,23(2):905. DOI: 10.3390/ijms23020905.
[10] 王娜,郭鹏. 来氟米特联合甲氨蝶呤治疗类风湿性关节炎疗效分析[J]. 北华大学学报(自然科学版),2023,24(5):622-625. DOI:10.11713/j.issn.1009-4822.2023.05.011.
[11] 邵宗钫,王健. 生地苦参汤加减联合塞来昔布对类风湿性关节炎患者骨代谢及免疫功能的影响[J]. 广州中医药大学学报,2023,40(12):3033-3040. DOI:10.13359/j.cnki.gzxbtcm.2023.12.012.
[12] 周丽琴,张菊. 塞来昔布对类风湿性关节炎患者血清生化指标影响及其疗效与安全性评价[J]. 中国生化药物杂志,2015(6):111-113,117.
[13] 刘丽敏,秦理. 类风湿性关节炎中医证型与免疫功能、凝血功能指标的关系[J]. 辽宁中医杂志,2023,50(2):84-87. DOI:10.13192/j.issn.1000-1719.2023.02.022.
[14] 常岑,张润润,时一鸣,等. 中医疗法治疗类风湿性关节炎的研究进展[J]. 中国中药杂志,2023,48(2):329-335. DOI:10.19540/j.cnki.cjcmm.20220922.502.
[15] 郑凤娥,刘有限,林煜芬. 浮针治疗腰背肌筋膜炎的疗效观察及对血清炎症因子的影响[J]. 上海针灸杂志,2023,42(4):385-390. DOI:10.13460/j.issn.1005-0957.2023.04.0385.
[16] 牛朝旭,王巧立,张彦蕾,等. 浮针联合药物治疗膝骨关节炎的疗效观察[J]. 上海针灸杂志,2023,42(2):170-174. DOI:10.13460/j.issn.1005-0957.2023.02.0170.
[17] 马志红,白玉,付爱玲. 浮针法治疗腰背肌筋膜疼痛综合征临床研究[J]. 新中医,2022,54(17):215-219. DOI:10.13457/j.cnki.jncm.2022.17.046.
[18] 万彬彬,何浩,金京娥. 塞来昔布联合旭痹舒汤剂治疗类风湿性关节炎疗效及对Th17/Tregs平衡的影响[J]. 中华中医药学刊,2020,38(10):194-197. DOI:10.13193/j.issn.1673-7717.2020.10.045.
[19] Su Q, Wang X, Li Y,et al. Efficacy, safety and the lymphocyte subset changes of low-dose IL-2 in patients with autoimmune rheumatic diseases: a systematic review and meta-analysis[J]. Rheumatol Ther, 2024,11(1):79-96.DOI: 10.1007/s40744-023-00620-7.
[20] 吴元胜,马茂潇,朱英杰,等. Th17/Treg在骨科疾病中的研究进展[J]. 中国骨质疏松杂志,2023,29(5):713-718. DOI:10.3969/j.issn.1006-7108.2023.05.018.
[21] 孙思东,边祥涛. 穴位贴敷辅助五味消毒饮对类风湿性关节炎患者免疫功能、Th17/Tregs平衡的影响[J]. 中国医院用药评价与分析,2022,22(3):293-296. DOI:10.14009/j.issn.1672-2124.2022.03.009.
[22] 赵双. 老年类风湿性关节炎患者外周循环中Th17/Treg免疫失衡与疾病活动的相关性[J]. 罕少疾病杂志,2023,30(7):82-84. DOI:10.3969/j.issn.1009-3257.2023.07.035.
[23] 万彬彬,杨惠琴. 尪痹舒通过调控Th17/Tregs平衡缓解类风湿关节炎进展[J]. 中国老年学杂志,2022,42(10):2481-2484. DOI:10.3969/j.issn.1005-9202.2022.10.047.
[24] 符仲华.浮针医学纲要[M].北京:人民卫生出版社,2016:10.
[25] Wan Q, Deng G, Yang S,et al. Efficacy and safety of floating needle therapy in the treatment of knee osteoarthritis: a protocol for systematic review and meta-analysis[J]. Medicine (Baltimore), 2021,100(6):e24505. DOI: 10.1097/MD.0000000000024505.